ESC 365 - Professor Jemma Hopewell

Speaker illustration

Professor Jemma Hopewell

University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)

Member of:

Sessions Presentations Articles

Pharmacogenomics, cardio-omics, and cardiovascular drugs

Event: ESC Congress 2024

Topic: Pharmacogenetics

Session type: Moderated ePosters

Young Investigator Award Session in Population Science, Genetics and Epidemiology

Event: ESC Congress 2024

Topic: European Society of Cardiology

Session type: Award Sessions

Impact of comorbidities on cardiovascular outcome in patients with atrial fibrillation

Event: ESC Congress 2023

Topic: Heart Failure in Atrial Fibrillation

Session type: Moderated ePosters

Risk factors for cognitive impairment in atrial fibrillation patients

Event: ESC Congress 2023

Topic: Cognitive Function and Autonomy in Patients with Atrial Fibrillation

Session type: Moderated ePosters

Risks and screening for atrial fibrillation

Event: ESC Congress 2023

Topic: Epidemiology, Prognosis, Outcome

Session type: Moderated ePosters

Atrial fibrillation and stroke: role of kidney disease and biomarkers

Event: ESC Congress 2023

Topic: Atrial Fibrillation (AF)

Session type: Abstract Sessions

Risk factors and prevention - Epidemiology 2

Event: ESC Congress 2022

Topic: Epidemiology

Session type: Moderated ePosters

Coronary artery disease - Epidemiology, prognosis, outcome 6

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session type: Moderated ePosters

Coronary artery disease - Epidemiology, prognosis, outcome 7

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session type: Moderated ePosters

Meet the trialist - Combined effect of lower LDL-C and lower SBP on the lifetime risk of cardiovascular disease

Event: ESC Congress 2019

Topic: Epidemiology

Session type: Late-Breaking Science

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources